FSMAX
Price
$114.97
Change
+$0.84 (+0.74%)
Updated
Sep 11 closing price
Net Assets
40.07B
PMEGX
Price
$52.44
Change
+$0.45 (+0.87%)
Updated
Sep 11 closing price
Net Assets
2.25B
Interact to see
Advertisement

FSMAX vs PMEGX

FSMAX vs PMEGX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. PMEGX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and PMEGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. PMEGX (2.25B). FSMAX pays higher dividends than PMEGX: FSMAX (0.49) vs PMEGX (0.11). FSMAX was incepted earlier than PMEGX: FSMAX (15 years) vs PMEGX (30 years). PMEGX (0.61) is less costly to investors than FSMAX (0.04). PMEGX is a more actively managed with annual turnover of: 28.80 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than PMEGX: FSMAX (0) vs PMEGX (1000000). FSMAX annual gain was more profitable for investors over the last year : 13.05 vs. PMEGX (-17.61). FSMAX return over 5 years is better than : 32.77 vs. PMEGX (-37.15).
FSMAXPMEGXFSMAX / PMEGX
Total Expense Ratio0.040.616%
Annual Report Gross Expense Ratio0.040.616%
Fund Existence15 years30 years-
Gain YTD13.3700.3284,076%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B2.25B1,783%
Annual Yield % from dividends0.490.11468%
Returns for 1 year13.05-17.61-74%
Returns for 3 years63.92-16.49-388%
Returns for 5 years32.77-37.15-88%
Returns for 10 years133.4216.21823%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NULG111.100.56
+0.51%
Nuveen ESG Large-Cap Growth ETF
RAAA25.060.03
+0.14%
Reckoner Yield Enhanced AAA CLO ETF
PUSH50.180.02
+0.04%
PGIM Ultra Short Municipal Bond ETF
SPTB29.20-0.03
-0.12%
State Street® SPDR® Portfolio Trs ETF
BIS11.96-0.03
-0.25%
ProShares UltraShort Nasdaq Biotech